Search Results - "Cojutti, Piergiorgio"

Refine Results
  1. 1

    Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach by PEA, Federico, VIALE, Pierluigi, COJUTTI, Piergiorgio, FURLANUT, Mario

    Published in Antimicrobial Agents and Chemotherapy (01-12-2012)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients by Cojutti, Piergiorgio, Pai, Manjunath P., Pea, Federico

    Published in Clinical pharmacokinetics (01-08-2018)
    “…Background Linezolid is an anti-Gram-positive antimicrobial agent used at a fixed dose of 600 mg every 12 h. Objectives The objective of this study was to…”
    Get full text
    Journal Article
  3. 3

    Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae by Cojutti, Piergiorgio, Sartor, Assunta, Righi, Elda, Scarparo, Claudio, Bassetti, Matteo, Pea, Federico

    Published in Antimicrobial agents and chemotherapy (01-10-2017)
    “…We assessed the population pharmacokinetics of high-dose continuous-infusion (HDCI) meropenem in a cohort of patients with carbapenemase (KPC)-producing…”
    Get full text
    Journal Article
  4. 4

    Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis by PEA, Federico, FURLANUT, Mario, COJUTTI, Piergiorgio, CRISTINI, Francesco, ZAMPARINI, Eleonora, FRANCESCHI, Loretta, VIALE, Pierluigi

    Published in Antimicrobial Agents and Chemotherapy (01-11-2010)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Successful Long-Term Treatment of Cerebral Nocardiosis with Unexpectedly Low Doses of Linezolid in an Immunocompromised Patient Receiving Complex Polytherapy by Pea, Federico, Cojutti, Piergiorgio, Pagotto, Alberto, Cristini, Francesco, Furlanut, Mario, Viale, Pierluigi

    Published in Antimicrobial Agents and Chemotherapy (01-06-2012)
    “…Cerebral nocardiosis is a severe infection that carries the highest mortality rate among all bacterial cerebral abscesses. We report on a case in an…”
    Get full text
    Journal Article
  7. 7

    Monitoring Polypharmacy in Healthcare Systems through a Multi-Setting Survey: Should We Put More Attention on Long Term Care Facilities? by Arnoldo, Luca, Cattani, Giovanni, Cojutti, Piergiorgio, Pea, Federico, Brusaferro, Silvio

    Published in Journal of public health research (09-12-2016)
    “…Background Polypharmacy is a main issue of patient safety in all healthcare settings (i.e. increase adverse drug reactions and incidence of drug-drug…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetic Interaction Between Everolimus and Antifungal Triazoles in a Liver Transplant Patient by Pea, Federico, Baccarani, Umberto, Tavio, Marcello, Cojutti, Piergiorgio, Adani, Gian Luigi, Londero, Angela, Baraldo, Massimo, Franceschi, Loretta, Furlanut, Mario, Viale, Pierluigi

    Published in The Annals of pharmacotherapy (01-11-2008)
    “…Objective: TO describe the management of a pharmacokinetic interaction between azole antifungals (fluconazole and voriconazole) and everolimus in a patient who…”
    Get full text
    Journal Article
  9. 9

    The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison by Pasca, Samantha, PierGiorgio, Cojutti, Pea, Federico

    Published in Journal of thrombosis and thrombolysis (01-11-2022)
    “…Background FXIII deficiency is a very rare coagulation disorder that can affect equally males and females with an estimated incidence of 1 in 2 million persons…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients by Cojutti, Piergiorgio, Maximova, Natalia, Pea, Federico

    Published in Antimicrobial agents and chemotherapy (01-09-2015)
    “…This study explored the pharmacokinetics and the pharmacodynamics of continuous-infusion meropenem in a population of pediatric hematopoietic stem cell…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients by PEA, Federico, VIALE, Pierluigi, COJUTTI, Piergiorgio, DEL PIN, Barbara, ZAMPARINI, Eleonora, FURLANUT, Mario

    Published in Journal of antimicrobial chemotherapy (01-08-2012)
    “…Prolonged treatment with linezolid may cause toxicity. The purpose of this study was to define pharmacodynamic thresholds for improving safety outcomes of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Limited sampling strategies for determining the area under the plasma concentration–time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosis by Cojutti, Piergiorgio, Giangreco, Manuela, Isola, Miriam, Pea, Federico

    “…Highlights • Isoniazid exposure following the standard dose may vary greatly between patients with tuberculosis. • Optimizing isoniazid exposure is becoming an…”
    Get full text
    Journal Article
  17. 17

    Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections by Bassetti, Matteo, Pecori, Davide, Cojutti, Piergiorgio, Righi, Elda, Pea, Federico

    “…In the era of multi-drug resistant pathogens, the adequate treatment of skin and skin structure infections remains a challenge for clinicians. Delafloxacin,…”
    Get more information
    Journal Article
  18. 18

    A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds? by Pea, Federico, Cojutti, Piergiorgio, Dose, Lucia, Baraldo, Massimo

    Published in British journal of clinical pharmacology (01-02-2016)
    “…Aim This study explored the clinical and economic impact of clinical pharmacological advice (CPA) (based on therapeutic drug monitoring [TDM] results, and on…”
    Get full text
    Journal Article
  19. 19

    Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring by Pai, Manjunath P., Cojutti, Piergiorgio, Pea, Federico

    Published in Clinical pharmacokinetics (01-08-2014)
    “…Background Levofloxacin is a commonly prescribed antimicrobial where recommendations exist to reduce doses for renal impairment but not to increase doses for…”
    Get full text
    Journal Article
  20. 20

    Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures by Franceschi, Loretta, Cojutti, Piergiorgio, Baraldo, Massimo, Pea, Federico

    Published in Therapeutic drug monitoring (01-10-2014)
    “…Administration by continuous infusion may represent an effective tool for the treatment of multidrug-resistant gram-negative related infections with meropenem…”
    Get full text
    Journal Article